Clinical Trial Update: Chinese Adults With Kidney Disease [Phase 2]

View source ↗

Summary

ADARx Pharmaceuticals is conducting a Phase 2 trial in Chinese adults with immunoglobulin A nephropathy, C3 glomerulopathy, or immune complex-mediated membranop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• C3 Glomerulopathy
• Immune Complex-mediated Membranoproliferative Glomerulonephritis
• Immunoglobulin Nephropathy

Drugs mentioned

• Investigational therapy (undisclosed)

Snippet

Sponsor: ADARx Pharmaceuticals, Inc. | Conditions: Immunoglobulin A Nephropathy (IgAN), Complement 3 Glomerulopathy (C3G) | Phase 2 | Status: RECRUITING